查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442588

全球活检设备市场评估：按产品类型、应用、最终用户、地区、机会、预测（2017-2031）

Biopsy Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5个工作天内

价格

全球切片设备市场规模预计将从 2023 年的 31 亿美元成长到 2031 年的 57.4 亿美元，预测期内复合年增长率为 8.03%。

据预测，由于全球癌症发病率增加、活检设备设计和功能的进步、对微创手术的需求增加以及监管支持等增长因素的影响，活检设备市场预计将增长。 此外，人工智慧和机器学习的整合预计将在活检设备行业的持续成长和创新中发挥关键作用。 全球癌症患者数量的增加是推动活检设备需求的主要驱动因素。 医疗基础设施的扩大、诊断实验室数量的增加以及政府透过准确、快速的诊断来减轻癌症疾病负担的支持也是促进活检设备市场扩大的因素。 此外，人们对癌症的认识不断提高以及诊断方法的便捷获取也推动了市场的成长。

另一方面，与使用活检设备相关的感染风险和不发达的医疗基础设施是阻碍市场成长的因素之一。 活检过程中感染传播的可能性很高，不仅对医护人员而且对病人构成重大挑战。

切片设备的进展

活检设备的最新进展集中在液体活检和骨骼活检设备。 液体活检分析来自体液的肿瘤来源信息，近年来在微光子学、奈米光子学和微流体技术进步的支持下取得了巨大进展。 这些技术能够检测循环肿瘤 RNA、无细胞 microRNA 和外泌体等分析物，与传统组织活检相比具有多种优势，包括非侵入性、重现性和快速结果。 另一方面，骨骼活检设备旨在收集小骨样本进行测试，这有助于早期发现和诊断癌症等疾病。 骨骼活检技术的最新进展包括创新设备的开发、组织采集技术的改进以及能够进入难以到达的肿瘤部位的磁针的探索。

癌症病人增加

由于需要早期检测和准确诊断疾病，越来越多的癌症患者增加了对活检设备的需求。 乳癌、肺癌、白血病等各种癌症的盛行率不断上升，对活检设备的需求产生了积极影响。 癌症患者数量的增加是由于多种因素造成的，包括辐射暴露增加、生活方式不当、工作时间长、压力增加、吸烟、饮酒和使用避孕措施。 据泛美卫生组织称，全球约有 2,000 万新发癌症病例和 1,000 万癌症相关死亡病例。 这给卫生系统、个人和社区带来了巨大的负担。 不幸的是，预计这一负担在未来 20 年将增加 60%。 这意味着到 2040 年，全球可能会新增约 3,000 万癌症病例，预计增幅最显着的将出现在低收入和中等收入国家。

北美成为主要地区

北美拥有较高的医疗保健支出、成熟的研发生态系统，并且注重早期疾病检测。 北美还拥有强大的医疗基础设施、完善的保险和自付系统以及积极的监管框架，这为该地区带来了优势。 该地区癌症和其他慢性病的盛行率也很高，导致对活检设备的强劲需求。 此外，北美的主要进入者的存在以及对监管审批的关注也有助于北美在活检设备市场的主导地位。

本报告调查了全球活检设备市场，提供了市场定义和概述、市场规模趋势和预测、各个细分市场和地区的详细分析、行业结构以及影响市场成长的因素。我们编制分析、案例研究、竞争格局、主要公司简介等等。

目录

第 1 章研究方法

第 2 章专案范围与定义

第 3 章执行摘要

第 4 章全球切片设备市场展望

  • 市场规模/预测
  • 依产品类型
    • 针式切片枪
    • 切片引导系统
    • 切片钳
    • 切片针
    • 其他
  • 依用途
    • 乳房切片检查
    • 肺活检
    • 大肠活检
    • 摄护腺切片检查
    • 其他
  • 按最终用户
    • 医院
    • 专科肿瘤中心
    • 诊断中心
    • 研究院
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美洲
    • 中东/非洲
  • 各公司的市占率

第 5 章全球切片设备市场展望：按地区

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东/非洲

第 6 章市场映射

  • 依产品类型
  • 依用途
  • 按最终用户
  • 按地区

第 7 章宏观环境与产业结构

  • 需求与供给分析
  • 汇入/汇出分析
  • 价值链分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市场动态

  • 生长促进因素
  • 生长抑制因素（问题/抑制因素）

第 9 章法律与监管架构/创新

  • 临床试验
  • 专利环境
  • 监理机关核准
  • 创新/新兴技术

第 10 章主要公司状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析
  • 併购/合资企业（如果适用）
  • SWOT 分析（5 家参与公司）

第 11 章价格分析

第 12 章案例研究

第 13 章主要公司展望

  • Becton, Dickinson and Company
  • Hologic Inc.
  • Danaher Corporation
  • Cook Medical
  • Boston Scientific Corporation
  • Argon Medical Devices
  • B. Braun Melsungen AG
  • Cardinal Health Inc.
  • Medtronic PLC
  • Olympus Corporation

第 14 章策略建议

第 15 章关于我们公司/免责声明

Product Code: MX11056

Global biopsy devices market is projected to witness a CAGR of 8.03% during the forecast period 2024-2031, growing from USD 3.1 billion in 2023 to USD 5.74 billion in 2031. The biopsy devices market is anticipated to thrive under the influence of growth factors like the growing prevalence of cancer cases globally, design and working advancements in biopsy devices, rising demand for minimally invasive procedures, and regulatory support. Additionally, the integration of artificial intelligence and machine learning is expected to play a pivotal role in the continued growth and innovation of the biopsy devices industry. The rising number of cancer cases at the global level is a major driver that drives the demand for biopsy devices. Growing healthcare infrastructure, a rising number of diagnostic laboratories, and government support for reducing the cancer disease burden through precise and rapid diagnostics are some other factors contributing to the expansion of the biopsy devices market. Furthermore, growing cancer awareness among common people and easy access to diagnostic methods propels market growth.

However, risks of infections associated with the use of biopsy devices and underdeveloped healthcare infrastructure are some factors hindering the growth of this market. During the biopsy process, the chances of infection spreading are high, posing a significant challenge for healthcare professionals as well as the patient.

In May 2023, Argon Medical Devices announced the launch of SuperCore Advantage semi-automatic biopsy instrument which is the newest addition to the company's soft tissue biopsy product portfolio in the United States. The SuperCore Advantage is a disposable soft tissue biopsy instrument that provides a larger tissue sample for more accurate analysis.

Advancements in Biopsy Devices

Recent advancements have been made in biopsy devices, with a focus on liquid biopsies and bone biopsy devices. Liquid biopsies involve the analysis of tumor-derived information from body fluids and have seen significant progress in recent years, supported by the development of microphotonics, nanophotonics, and microfluidics technologies. These technologies enable the detection of analytes, such as circulating tumor RNA, cell-free micro-RNA, and exosomes, and offer several benefits over traditional tissue biopsies, including non-invasiveness, repeatability, and quick results. Meanwhile, bone biopsy devices are designed to remove small bone samples for examination, aiding in the early detection and diagnosis of diseases such as cancer. Recent advancements in bone biopsy technology include the development of innovative devices, improvements in tissue sampling techniques, and the exploration of magnetic needles that can access difficult-to-reach tumor sites.

In November 2023, Illumina Inc. introduced a new version of its TruSight Oncology 500 ctDNA assay, which is designed to provide genomic profiling for circulating tumor DNA (ctDNA) from the blood when tissue-based testing is not possible or to complement tissue-based testing. The new research assay, known as TruSight Oncology 500 ctDNA v2, is a distributed liquid biopsy assay that offers comprehensive genomic profiling (CGP) for ctDNA.

Growing Number of Cancer Cases

The growing number of cancer cases increases the demand for biopsy devices due to the need for early disease detection and accurate diagnosis. The rising prevalence of different types of cancers, such as breast cancer, lung cancer, and leukemia, is positively impacting the demand scenario for biopsy devices. The growing number of cancer cases is attributed to the growing exposure to radiation, inadequate lifestyle, longer working hours, increasing stress, smoking, alcohol consumption, use of contraception, and many more. According to the Pan America Health Organization, globally, around 20 million new cases of cancer and 10 million cancer-related deaths were reported. This puts a considerable burden on health systems, individuals, and communities. Unfortunately, it is predicted that this burden will increase by 60% over the next two decades. This means that by 2040, there could be about 30 million new cases of cancer worldwide, with the most significant increase happening in low- and middle-income countries.

Dominance of Needle-based Biopsy Guns Segment

The needle-based biopsy guns segment dominates the biopsy devices market, with the largest market share. Needle-based biopsy guns are preferred for their precise and minimally invasive tissue collection, aiding in the diagnosis of various medical conditions, especially cancers. Ongoing advancements in needle design for improved accuracy, enhanced safety features, and the integration of imaging technologies, such as ultrasound guidance, are contributing to the growth of this segment. Needle biopsies are minimally invasive procedures that can be performed quickly and with relatively low risk, making them preferable for both patients and healthcare providers. The increasing demand for the gentle and rapid procurement of cell samples for biopsy is also contributing to the growth of this segment.

In October 2023, Praxis Medical obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its EndoCore Endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA) fine needle biopsy device. This American medical device company has created the EndoCore EBUS-TBNA biopsy device to aid in the diagnosis and staging of lung cancer. The procedure involves inserting a long, flexible tiny needle through a bronchoscope to perform a biopsy and pathological analysis.

Breast Biopsy Segment to Dominate the Market

The breast cancer segment is expected to dominate the global biopsy devices market. Breast cancer, being the most prevalent type of cancer, takes up the major share in the biopsy device market. The increasing number of breast cancer screening programs and the emergence of liquid biopsy and promising clinical trials are driving this growth. Manufacturers are attempting efforts to cater to the significantly high demand for breast cancer biopsy devices. For instance, in March 2023, TransMed7, LLC announced the first clinical use of VacuPac, which is a new self-contained external vacuum-assist attachment. It comes with a SpeedBird Universal and a Concorde US from the SpeedBird and Concorde families of vacuum-assisted, Single Insertion - Multiple Collection (SIMC) breast biopsy devices. This announcement comes after the previous announcements made by TransMed7 in August 2022 and February 2023 about the first clinical uses of SpeedBird and Concorde biopsy devices. These announcements were made as part of the commercial launch of TransMed7's vacuum assisted, SIMC breast biopsy devices.

North America to be the Dominating Region

North America is the leading region in the biopsy devices market, which is due to several factors. The region has a high healthcare expenditure, a robust research and development ecosystem, and an emphasis on early disease detection. Additionally, North America benefits from a strong healthcare infrastructure, a well-established system for insurance and co-payment, and a proactive regulatory framework, which further reinforces its dominance. The region also has a high prevalence of cancer and other chronic diseases, leading to a robust demand for biopsy devices. Furthermore, the presence of key market players and a focus on regulatory approvals in North America contributes to its leading position in the biopsy devices market.

For instance, in September 2023, Limaca Medical received clearance from the United States Food and Drug Administration (FDA) for its Precision GI endoscopic ultrasound (EUS) biopsy device. The FDA granted the device a breakthrough device designation, and with this new approval, Limaca Medical's automated device can obtain biopsies for definitive pancreatic cancer and gastrointestinal cancer diagnoses more quickly and with less trauma than existing products.

Future Market Scenario (2024 - 2031F)

The regulatory emphasis on biopsy devices is evident in the FDA regulations, which classify biopsy devices used in gastroenterology and urology under three categories, gastroenterology-urology biopsy instruments, endoscopes and accessories, and endoscopic electrosurgical units and accessories. The development of liquid biopsies for cancer screening also requires careful planning to meet regulatory demands, with evolving regulatory pathways and the need for analytical and clinical validation studies. The regulatory strategies for liquid biopsy diagnostics depend on a framework developed by the US Food and Drug Administration, with evolving guidance documents and regulatory approval precedents. The complexity of regulatory permutations for liquid biopsy diagnostics is influenced by specific indications and companion diagnostic claims associated with the products. Conclusively, a rising number of regulatory-approved biopsy devices is anticipated to cultivate healthy competition in the market and contribute to its expansion.

For instance, in November 2023, Single Pass, Inc. announced that it has received a CE Mark under EU MDR for its Kronos Biopsy Closure device. The cautery device is useful in stopping bleeding caused by biopsy tools during co-axial biopsy procedures. It is most used in liver, kidney, lung, and breast biopsy procedures.

Key Players Landscape and Outlook

The key players in the biopsy devices market include both global as well as local companies that operate in the market through a vast network of distributors. Some of the major players in the global biopsy devices market are Becton, Dickinson and Company, Hologic Inc., Danaher Corporation, Cook Medical, Boston Scientific Corporation, Argon Medical Devices, and B. Braun Melsungen AG. These companies are mainly involved in the strategic product development, research, and approval process. Various mergers and acquisitions and collaborations have been observed in recent years, showing the activeness of the key market players.

In June 2023, Quest Diagnostics, a prominent provider of diagnostic information services, announced the completion of its acquisition of Haystack Oncology. The latter is a company that has developed a highly sensitive minimal-residual disease (MRD) testing technology, which is based on circulating tumor DNA (ctDNA). This technology can aid in the early detection of residual or recurring cancer and better inform therapy decisions. Quest plans to incorporate this MRD technology into the development of new blood-based clinical lab services for solid tumor cancers, which will be available starting in 2024.

In March 2023, OraSure collaborated with nRichDx to offer products for researchers who are developing urine-based liquid biopsy assays. Colli-Pee, a sample collection and preservation device, is created by OraSure's subsidiary Novosanis. This device uses a proprietary reagent that allows hygienic collection of a consistent, volumetric first-void urine sample. It also preserves cell-free nucleic acids, such as cfDNA and cfRNA. At the same time, the Revolution Sample Prep System, which has been developed by nRichDX in Irvine, CA, is a semi-automated cfDNA sample prep system. It can process up to 20 mL of urine in a single extraction.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Biopsy Devices Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Needle-based Biopsy Guns
      • 4.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
      • 4.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
      • 4.2.1.3. Core Needle Biopsy (CNB) Devices
    • 4.2.2. Biopsy Guidance Systems
      • 4.2.2.1. Manual
      • 4.2.2.2. Robotic
    • 4.2.3. Biopsy Forceps
      • 4.2.3.1. General Biopsy Forceps
      • 4.2.3.2. Hot Biopsy Forceps
    • 4.2.4. Biopsy Needles
      • 4.2.4.1. Disposable
      • 4.2.4.2. Reusable
    • 4.2.5. Others
  • 4.3. By Application
    • 4.3.1. Breast Biopsy
    • 4.3.2. Lung Biopsy
    • 4.3.3. Colorectal Biopsy
    • 4.3.4. Prostate Biopsy
    • 4.3.5. Others
  • 4.4. By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Specialized Oncology Centers
    • 4.4.3. Diagnostic Centers
    • 4.4.4. Research Institutes
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Biopsy Devices Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Needle-based Biopsy Guns
      • 5.1.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
      • 5.1.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
      • 5.1.2.1.3. Core Needle Biopsy (CNB) Devices
      • 5.1.2.2. Biopsy Guidance Systems
      • 5.1.2.2.1. Manual
      • 5.1.2.2.2. Robotic
      • 5.1.2.3. Biopsy Forceps
      • 5.1.2.3.1. General Biopsy Forceps
      • 5.1.2.3.2. Hot Biopsy Forceps
      • 5.1.2.4. Biopsy Needles
      • 5.1.2.4.1. Disposable
      • 5.1.2.4.2. Reusable
      • 5.1.2.5. Others
    • 5.1.3. By Application
      • 5.1.3.1. Breast Biopsy
      • 5.1.3.2. Lung Biopsy
      • 5.1.3.3. Colorectal Biopsy
      • 5.1.3.4. Prostate Biopsy
      • 5.1.3.5. Others
    • 5.1.4. By End-user
      • 5.1.4.1. Hospitals
      • 5.1.4.2. Specialized Oncology Centers
      • 5.1.4.3. Diagnostic Centers
      • 5.1.4.4. Research Institutes
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product Type
      • 5.1.5.2.1. Needle-based Biopsy Guns
      • 5.1.5.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
      • 5.1.5.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
      • 5.1.5.2.1.3. Core Needle Biopsy (CNB) Devices
      • 5.1.5.2.2. Biopsy Guidance Systems
      • 5.1.5.2.2.1. Manual
      • 5.1.5.2.2.2. Robotic
      • 5.1.5.2.3. Biopsy Forceps
      • 5.1.5.2.3.1. General Biopsy Forceps
      • 5.1.5.2.3.2. Hot Biopsy Forceps
      • 5.1.5.2.4. Biopsy Needles
      • 5.1.5.2.4.1. Disposable
      • 5.1.5.2.4.2. Reusable
      • 5.1.5.2.5. Others
      • 5.1.5.3. By Application
      • 5.1.5.3.1. Breast Biopsy
      • 5.1.5.3.2. Lung Biopsy
      • 5.1.5.3.3. Colorectal Biopsy
      • 5.1.5.3.4. Prostate Biopsy
      • 5.1.5.3.5. Others
      • 5.1.5.4. By End-user
      • 5.1.5.4.1. Hospitals
      • 5.1.5.4.2. Specialized Oncology Centers
      • 5.1.5.4.3. Diagnostic Centers
      • 5.1.5.4.4. Research Institutes
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Becton, Dickinson and Company
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Hologic Inc.
  • 13.3. Danaher Corporation
  • 13.4. Cook Medical
  • 13.5. Boston Scientific Corporation
  • 13.6. Argon Medical Devices
  • 13.7. B. Braun Melsungen AG
  • 13.8. Cardinal Health Inc.
  • 13.9. Medtronic PLC
  • 13.10. Olympus Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Biopsy Devices Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 10. North America Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 16. United States Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 21. Canada Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 26. Mexico Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 31. Europe Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 37. Germany Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 42. France Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 43. France Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 47. Italy Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 52. United Kingdom Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 57. Russia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 62. Netherlands Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Spain Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Turkey Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 77. Poland Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 82. South America Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 88. Brazil Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 93. Argentina Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 98. Asia-Pacific Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 101. India Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 104. India Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 105. India Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 109. China Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 110. China Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 114. Japan Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 119. Australia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 124. Vietnam Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 129. South Korea Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Indonesia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 139. Philippines Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 144. Middle East & Africa Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 150. Saudi Arabia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 155. UAE Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 160. South Africa Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023